文献速递血栓与止血

静脉血栓形成分子机制研究进展

Advances in understanding the molecular mechanisms of venous thrombosis.
PubMed 文献 · Br J Haematol · 2019-03-24

本文综述了静脉血栓栓塞症(VTE)发病机制的研究进展,除遗传性凝血异常外,还涉及炎症内皮、血细胞、接触途径因子、蛋白质二硫键异构酶及肠道共生菌代谢物等新发现的分子与细胞决定因素。这些进展为开发疗效更佳、安全性更好的新型抗血栓疗法提供了机会。

要点

  • VTE是全球主要死亡原因之一,其血栓形成的决定因素尚未完全阐明。
  • 炎症内皮及对炎症刺激的失调反应为病理性血栓形成创造条件。
  • 血细胞、接触途径因子和蛋白质二硫键异构酶在VTE发展中起关键作用。

核心结论

  • 综述更新了VTE分子机制的最新进展,指出除遗传性凝血异常外,炎症内皮、血细胞、接触途径因子、蛋白质二硫键异构酶及肠道菌代谢物均参与VTE发病,为新型抗血栓疗法提供机会。

研究设计与样本

  • 综述类文章,检索范围原文未报告。

主要发现

  • 炎症内皮及对炎症刺激的失调反应形成病理性血栓形成的平台。
  • 血细胞、接触途径因子和蛋白质二硫键异构酶均在VTE发展中起关键作用。
  • 肠道共生菌来源的代谢物可能促进VTE。

关键数值与推荐

  • 原文未报告具体标准与数值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Venous thromboembolism (VTE) represents a leading cause of global mortality, however, the determinants that contribute to thrombus development remain incompletely understood. In this review, we discuss the role of inherited abnormalities of blood coagulation in VTE pathogenesis. In addition, we also consider recent emerging data suggesting other molecular and cellular determinants may also contribute. Specifically, we describe the role played by the inflamed endothelium, and the dysregulated responses to inflammatory stimuli that create a platform for pathological clot formation. We review the accumulating evidence that blood cells, contact pathway factors and protein disulphide isomerases all play key roles in VTE development. Finally, we discuss new insights into the role of metabolites arising from commensal gut bacteria and their potential role in facilitating VTE. This overview provides an update on these state-of-the-art developments and the opportunities they provide for new antithrombotic therapies with enhanced efficacy and improved safety profiles.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Preston RJS, O'Sullivan JM, O'Donnell JS, et al. Advances in understanding the molecular mechanisms of venous thrombosis. Br J Haematol. 2019. PMID: 30906986. doi:10.1111/bjh.15869

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。